Teneligliptin (MP-513) hydrobromide hydrate is an orally active and selective dipeptidyl peptidase 4 (DPP-4) inhibitor (IC50s: 0.37 and 0.29 nM for the human and rat DPP-4, respectively). Teneligliptin hydrobromide hydrate improves blood glucose levels and can be used in researches related to type 2 diabetes mellitus[1][2][3][4][5][6][7][8].
Molecular Weight:
426.58
Purity:
99.97
CAS Number:
[1572583-29-9]
Formula:
C22H30N6OS
Target:
AMPK,Apoptosis,Interleukin Related,JNK,NF-kappaB,NOD-like Receptor (NLR),p38 MAPK,Reactive Oxygen Species (ROS),Toll-like Receptor (TLR)
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted